|
| U.S. Brand
Names |
|
| Halotex® |

|
|
| Generic
Available |
|
|
No |

|
|
| Pharmacological Index |
|
|
Antifungal Agent, Topical |

|
|
| Use |
|
|
Topical treatment of tinea pedis (athlete's foot), tinea cruris (jock itch),
tinea corporis (ringworm), tinea manuum caused by Trichophyton rubrum,
Trichophyton tonsurans, Trichophyton mentagrophytes,
Microsporum canis, or Epidermophyton floccosum; topical treatment of
Malassezia furfur |

|
|
| Pregnancy Risk
Factor |
|
|
B |

|
|
| Contraindications |
|
|
Hypersensitivity to haloprogin or any component |

|
|
| Warnings/Precautions |
|
|
Safety and efficacy have not been established in
children |

|
|
| Adverse
Reactions |
|
|
<1%: Pruritus, folliculitis, vesicle formation, erythema, irritation,
burning sensation |

|
|
| Drug
Interactions |
|
|
No data reported |

|
|
| Mechanism of
Action |
|
|
Interferes with fungal DNA replication to inhibit yeast cell respiration and
disrupt its cell membrane |

|
|
| Pharmacodynamics/Kinetics |
|
|
Absorption: Poorly through the skin (~11%)
Metabolism: To trichlorophenol
Elimination: In urine, 75% as unchanged drug |

|
|
| Usual Dosage |
|
|
Topical: Children and Adults: Apply liberally twice daily for 2-3 weeks;
intertriginous areas may require up to 4 weeks of treatment |

|
|
| Mental Health: Effects
on Mental Status |
|
|
None noted |

|
|
| Mental Health:
Effects on Psychiatric
Treatment |
|
|
None noted |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
Avoid contact with eyes; for external use only; improvement should occur
within 4 weeks; discontinue use if sensitization or irritation
occur |

|
|
| Nursing
Implications |
|
|
Avoid contact with eyes; for external use only; improvement should occur
within 4 weeks; discontinue use if sensitization or irritation
occur |

|
|
| Dosage Forms |
|
|
Cream: 1% (15 g, 30 g)
Solution, topical: 1% with alcohol 75% (10 mL, 30 mL)
|

|
|
Copyright © 2007 Drugs Area
|